Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis

27 Dec 2011

Abstract excerpt

Despite considerable advances in the treatment of multiple sclerosis, current drugs are only partially effective. Most patients show reduced disease activity with therapy, but still experience relapses, increasing disability, and new brain lesions. Since there are no reliable clinical or biological markers of disease progression, long-term prognosis is difficult to predict for individual patients. We identified...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to Multiple Sclerosis Research Studies
Share to NF-κB Signaling Pathways

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22216338
DOI: 10.1371/journal.pone.0029648

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple SclerosisPMID 22216338Read ↗

Gene-expression signatures: biomarkers toward diagnosing multiple sclerosisSemantic proximity Read ↗

A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patientsSemantic proximity Read ↗

Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosisSemantic proximity Read ↗

Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission.Semantic proximity Read ↗

Pharmacogenomics and multiple sclerosis: moving toward individualized medicine.Semantic proximity Read ↗

Peripheral blood gene expression signature mirrors central nervous system disease: The model of multiple sclerosisSemantic proximity Read ↗

Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.Semantic proximity Read ↗

Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery?Semantic proximity Read ↗

RORC and Foxp3 axis in cerebrospinal fluid of patients with Neuro-Behçet's DiseaseSemantic proximity Read ↗

Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.Semantic proximity Read ↗

Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?Semantic proximity Read ↗

Transcriptomic Profile Reveals Gender-Specific Molecular Mechanisms Driving Multiple Sclerosis ProgressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.